Table 1 Patient characteristics

Age, mean ± SD, years

61.4 ± 9.84

Gender

 Male

64 (79%)

 Female

17 (21%)

Tumor staging

 pTis/Cis

1 (1.2%)

 pT1

4 (4.9%)

 pT2a

5 (6.2%)

 pT2b

14 (17.3%)

 pT3a

33 (40.8%)

 pT3b

19 (23.5%)

 pT4a

4 (4.9%)

 pT4b

1 (1.2%)

LN status

 Nx

1 (1.2%)

 N0

12 (14.8%)

 N1

22 (27.2%)

 N2

38 (46.9%)

 N3

8 (9.9%)

Metastasis

 Yes

36 (44.4%)

 No

45 (55.6%)

Recurrence

 Yes

39 (48.1%)

 No

42 (51.9%)

Death

 Yes

52 (64.2%)

 No

29 (35.8%)

Histological type

 Pure Urothelial carcinoma

69 (85.2%)

 Micropapillary carcinoma

4 (4.9%)

 Sarcomatoid carcinoma

6 (7.5%)

 Adenocarcinoma

1 (1.2%)

 No residual invasive tumor

1 (1.2%)

Chemotherapy type

 Cisplatin

36 (44.4%)

 MVAC

18 (22.2%)

 CMV

17 (20.9%)

 Carboplatin

10 (12.3%)